Regulated multimodal digital biomarker platform using wearable data and AI to convert subjective fatigue into objective, clinically actionable daily fatigue risk scores. Targets people with fluctuating autoimmune conditions (Rheumatoid Arthritis, Lupus, MS) and clinicians, enabling activity pacing to prevent fatigue crashes and real-time distinction between behavioural fatigue and early disease deterioration.